The Senate last night voted 92-2 to approve the conference report to the Comprehensive Addiction and Recovery Act (S. 524), legislation designed to help stem the epidemic of opioid abuse through education, prevention, treatment and rehabilitation. The bill incorporates several key AHA-endorsed measures, including the creation of a multi-agency task force with a hospital representative that will develop best practices for prescribing and pain management; more stringent pre-market review of new opioids by the Food and Drug Administration; increased access to opioid overdose reversal drugs and medication-assisted treatment; and expanded research and treatment for vulnerable populations. The House passed the conference report last week and President Obama is expected to sign it into law. AHA members today received a Special Bulletin with more on the legislation, as well as recent actions by the administration and AHA to combat the opioid abuse epidemic. 

Related News Articles

Headline
Aetna’s new “level of severity inpatient payment” policy is now set to take effect Jan. 1, 2026, the company recently announced, along with providing…
Headline
A joint advisory issued yesterday by U.S. and international agencies provides updated guidance to defend against the Akira ransomware group, which…
Headline
Health care executives will share trauma-informed strategies to reduce violence, support staff and foster healing during an AHA webinar Dec…
Perspective
Public
Nov. 20 is National Rural Health Day. It’s an opportunity to recognize the many ways rural hospitals advance health in their communities, as well as raise…
Headline
The 43-day government shutdown ended last night when President Trump signed a funding bill into law, hours after the House passed the measure by a 222-209 vote…
Headline
Medicaid enrollment decreased 7.6% in fiscal year 2025 and is expected to be mostly flat in FY 2026, according to KFF’s annual Medicaid Budget Survey released…